Zymo Research, established in 1994 and based in the United States, operates within the Business Services industry, specifically focusing on biotech and pharmaceuticals. The company employs between 51 and 200 individuals and reported revenue of approximately $22.8 million. Zymo Research specializes in developing innovative solutions for DNA and RNA extraction, purification, and analysis, with a significant emphasis on microbiome research. Their published document, "Considerations for Building an Accurate Shotgun Metagenomic Workflow for Gut Microbiome Profiling," outlines methodologies and best practices for utilizing shotgun metagenomics in studying the human gut microbiome. This document highlights the importance of high-throughput DNA sequencing techniques and discusses the advantages of shotgun metagenomic workflows over targeted sequencing methods. It addresses key challenges and considerations in microbiome profiling, including accuracy, reproducibility, and the sensitivity of sequencing methods. Zymo Research's expertise is evident in their commitment to advancing research in microbiome analysis and providing practical guidance for researchers in the field.